Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Aged Volunteers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02822612
What this trial is testing

The EASE Study - Human Factor and Usability Testing of a Binocular OCT System

Who this might be right for
GlaucomaRetinal DiseaseStrabismus+1 more
University College, London 60
Early research (Phase 1)Study completedNCT01051700
What this trial is testing

A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans

Who this might be right for
Macular Degeneration
GlaxoSmithKline 72
Early research (Phase 1)Study completedNCT06237296
What this trial is testing

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Sanofi Pasteur, a Sanofi Company 558
Early research (Phase 1)Study completedNCT03316521
What this trial is testing

First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers

Who this might be right for
Complement Mediated Diseases
Amyndas Pharmaceuticals S.A. 50
Not applicableStudy completedNCT00029120
What this trial is testing

Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder

Who this might be right for
Alzheimer DiseaseDementiaMemory Disorder+1 more
National Institute of Mental Health (NIMH) 450
Early research (Phase 1)Study completedNCT04476303
What this trial is testing

Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants

Who this might be right for
Alzheimer's Disease
BeyondBio Inc. 88
Early research (Phase 1)Study completedNCT05987488
What this trial is testing

ShigETEC Vaccine Study in Bangladesh

Who this might be right for
Healthy Volunteers
Eveliqure Biotechnologies GmbH 196
Very early researchStudy completedNCT02844621
What this trial is testing

Effect of Proton Pump Inhibitors on Gut Microbiota and Systemic Inflammation in Older Adults

Who this might be right for
Healthy Volunteers
The University of Texas Health Science Center at San Antonio 25
Large-scale testing (Phase 3)Study completedNCT02147548
What this trial is testing

Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly

Who this might be right for
Healthy Volunteers
Biocodex 31
Early research (Phase 1)Study completedNCT04169906
What this trial is testing

A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)

Who this might be right for
Healthy Volunteer
Taisho Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT04824638
What this trial is testing

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers

Who this might be right for
HealthyImmunization; Infection
ANRS, Emerging Infectious Diseases 267
Early research (Phase 1)Study completedNCT01953848
What this trial is testing

Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)

Who this might be right for
EC905PharmacokineticsMultiple Dose+1 more
Astellas Pharma Europe B.V. 27
Not applicableLooking for participantsNCT06620185
What this trial is testing

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Who this might be right for
Influenza
Imperial College London 36
Not applicableStudy completedNCT00026598
What this trial is testing

Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 90
Testing effectiveness (Phase 2)Study completedNCT00161772
What this trial is testing

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Who this might be right for
Tick-borne Encephalitis
Pfizer
Large-scale testing (Phase 3)Study completedNCT03890367
What this trial is testing

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers

Who this might be right for
Meningococcal Immunisation (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 707
Early research (Phase 1)Study completedNCT01477619
What this trial is testing

Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects

Who this might be right for
Healthy Volunteers
Vanda Pharmaceuticals 60
Testing effectiveness (Phase 2)UnknownNCT05409300
What this trial is testing

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Who this might be right for
COVID-19Vaccine Adverse ReactionSars-CoV-2 Infection+1 more
ANRS, Emerging Infectious Diseases 200
Post-approval studies (Phase 4)Study completedNCT01863433
What this trial is testing

Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers

Who this might be right for
Influenza, Human
Seqirus 120
Large-scale testing (Phase 3)Study completedNCT01173562
What this trial is testing

A Safety Study of Mebendazole in Children 2 to 10 Years of Age

Who this might be right for
Healthy Volunteers
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 397
Next Page